SLIDESHOW: Top 10 Cheap Dividend Stocks
By Dividend Channel Staff, updated Wed, April 24, 8:37 PM
This Slide: #1 of 10 |
#10. Royalty Pharma
Trading Symbol
RPRX
Recent Price
27.98
Dividend Yield
3.00%
TTM Earnings
4.38
PE Ratio (TTM)
6.4
Market Cap
12.5B
#10. Royalty Pharma
Trading Symbol
RPRX
Recent Price
27.98
Dividend Yield
3.00%
TTM Earnings
4.38
PE Ratio (TTM)
6.4
Market Cap
12.5B
Royalty Pharma is a buyer of biopharmaceutical royalties. The royalties in Co.'s marketed portfolio related to approved products include: cystic fibrosis franchise, which consists of Co.'s right to receive royalty payments on the sale of various products for use in the treatment of cystic fibrosis, including Kalydeco (ivacaftor), Orkambi (lumacaftor and ivacaftor), Symdeko/Symkevi (tezacaftor and ivacaftor) and Trikafta/Kaftrio (elexacaftor, tezacaftor and ivacaftor); and Tysabri, which is a monoclonal antibody for the treatment of relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease. More details about Royalty Pharma at: http://www.royaltypharma.com.
View RPRX's Dividend History » ETFs holding RPRX »
Should Royalty Pharma shares be counted among the Top 10 Cheap Dividend Stocks label? To start, we see that the recent trading price for RPRX stock is $27.98 and the dividend yield is 3.00% (as of 4/24/2024). The most recent quarter's (MRQ) earnings result, annualized, was $4.6/share. Looking at the sum total of quarterly earnings across the trailing twelve month (TTM) period, Royalty Pharma produced $4.38/share. And taking the median quarterly result across the TTM period, and annualizing it, results in $3.96/share. Comparing the current indicated annual dividend rate of $0.84 against that median result, we calculate a dividend payout ratio of 21.2%. Comparing the company's various earnings metrics against the stock price, we end up with a PE ratio of 7.1 for the TTM Median method, 6.1 for price to earnings using MRQ annualized, and 6.4 for current price/TTM earnings. Based on RPRX's history, that recent TTM PE is low relative to the historical average, with the recent PE 69.4% lower than the average (TTM method) of 20.9.
Should Royalty Pharma shares be counted among the Top 10 Cheap Dividend Stocks label? To start, we see that the recent trading price for RPRX stock is $27.98 and the dividend yield is 3.00% (as of 4/24/2024). The most recent quarter's (MRQ) earnings result, annualized, was $4.6/share. Looking at the sum total of quarterly earnings across the trailing twelve month (TTM) period, Royalty Pharma produced $4.38/share. And taking the median quarterly result across the TTM period, and annualizing it, results in $3.96/share. Comparing the current indicated annual dividend rate of $0.84 against that median result, we calculate a dividend payout ratio of 21.2%. Comparing the company's various earnings metrics against the stock price, we end up with a PE ratio of 7.1 for the TTM Median method, 6.1 for price to earnings using MRQ annualized, and 6.4 for current price/TTM earnings. Based on RPRX's history, that recent TTM PE is low relative to the historical average, with the recent PE 69.4% lower than the average (TTM method) of 20.9.
RPRX Next Dividend Date » (Projection based upon history) RPRX Dividend Growth Rate » Quotes delayed 20 minutes |
Strong Buy (3.79 out of 4) 73rd percentile
(ranked higher than approx. 73% of all stocks covered)
Analysts' Target Price: RPRX Forecast Based on data provided by Zacks Investment Research via Quandl.com |
|